Doctors swear an oath to first, do no harm, and are expected to use treatments supported by evidence or, at minimum, a plausible expectation of benefit outweighing risks
Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial
Each child should have a thorough medical evaluation before therapy, and the treatment protocol should be tailored to their health history, test results, and current therapies
PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan), with your dose adjusted as neededbut your price stays the same regardless of dose level
I have pernicious anemia
Peptide Vials 5 mg AOD-9604 vials